April 29, 2026 Evercore Reports Record First Quarter 2026 Revenues; Increases Quarterly Dividend to $0.89 Per Share
April 29, 2026 Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
April 29, 2026 Phillips 66 Reports First-Quarter Results: Expanded Capacity and Continued Strong Operations
